Lobbying Information
Subject Matters
- Aboriginal Affairs
- Consumer Issues
- Defence
- Government Procurement
- Health
- Justice and Law Enforcement
- Research and Development
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Eligibility for Scientific Research and Experimental Development tax incentives.
- Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
Policies or Program
- To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Canada Revenue Agency (CRA)
-
Correctional Service of Canada (CSC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
National Defence (DND)
-
Prairies Economic Development Canada (PrairiesCan)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Safety Canada (PS)
-
Royal Canadian Mounted Police (RCMP)
-
Senate of Canada
-
Veterans Affairs Canada (VAC)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
2476 Argentia, Suite 403
Mississauga, ON L5N 6M1
Canada
Telephone number:
204-275-4200
Web address:
www.emergentbiosolutions.com
Client representative
David Renwick, General Manager, Canada
Parent Company Information
- Emergent BioSolutions Inc. / Emergent BioSolutions Inc.
-
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
United States of America
Coalition Members Information
Emergent BioSolutions Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Emergent BioSolutions Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Emergent BioSolutions Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Sheamus Murphy
|
Public offices held
Business address:
95 St. Clair Ave, West
Suite 1606
Toronto, ON M4V 1N6
Canada
Telephone number:
416-920-0716
Ext.
223
Fax number:
416-352-6069
Consultant Firm and Address
Firm:
Counsel Public Affairs Inc.
Address:
95 St. Clair Avenue West
Suite 1606
Toronto, ON M4V 1N6
Canada
Telephone number:
416-920-0716
Ext.
223
Fax number:
416-352-6069
